Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 247,862 shares at $91.60 ($22.6M) on 2019-08-29, disclosed to the SEC on 2019-09-03.
Open-market sale of $22.6M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.58 | 57,913 | $5.2M | 23.2% |
| 2 | $90.58 | 57,913 | $5.2M | 23.2% |
| 3 | $91.60 | 65,768 | $6.0M | 26.7% |
| 4 | $91.60 | 65,768 | $6.0M | 26.7% |
| 5 | $92.00 | 500 | $46K | 0.2% |
| Total | $91.12 avg | 247,862 |
| $22.6M |
| 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |